These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7655381)

  • 1. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
    Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
    Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of cytomegalovirus and Epstein-Barr virus expression in labial salivary glands of patients with chronic graft-versus-host disease.
    Mariette X; Cazals-Hatem D; Agbalika F; Selimi F; Brunet M; Morinet F; Gluckman E
    Bone Marrow Transplant; 1996 Apr; 17(4):607-10. PubMed ID: 8722363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
    Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist VA
    Transplantation; 1995 Nov; 60(9):961-5. PubMed ID: 7491701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship.
    Takemoto Y; Takatsuka H; Wada H; Mori A; Saheki K; Okada M; Tamura S; Fujimori Y; Okamoto T; Kakishita E; Kanamaru A
    Bone Marrow Transplant; 2000 Jul; 26(1):77-81. PubMed ID: 10918408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.
    Schmidt CA; Oettle H; Wilborn F; Jessen J; Timm H; Schwerdtfeger R; Oertel J; Siegert W
    Bone Marrow Transplant; 1994 Jan; 13(1):71-5. PubMed ID: 8019456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea.
    Einsele H; Ehninger G; Hebart H; Weber P; Dette S; Link H; Horny HP; Meuter V; Wagner S; Waller HD
    Bone Marrow Transplant; 1994 Dec; 14(6):955-63. PubMed ID: 7711674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
    Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in the colon of bone marrow transplantation patients.
    Kraus MD; Feran-Doza M; Garcia-Moliner ML; Antin J; Odze RD
    Mod Pathol; 1998 Jan; 11(1):29-36. PubMed ID: 9556420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.
    Vassallo C; Brazzelli V; Alessandrino PE; Varettoni M; Ardigò M; Lazzarino M; Borroni G
    Br J Dermatol; 2004 Sep; 151(3):579-86. PubMed ID: 15377343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.
    Maeda Y; Teshima T; Yamada M; Shinagawa K; Nakao S; Ohno Y; Kojima K; Hara M; Nagafuji K; Hayashi S; Fukuda S; Sawada H; Matsue K; Takenaka K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Br J Haematol; 1999 Apr; 105(1):295-302. PubMed ID: 10233397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease.
    Matthes-Martin S; Aberle SW; Peters C; Holter W; Popow-Kraupp T; Pötschger U; Fritsch G; Ladenstein R; Rosenmayer A; Dieckmann K; Gadner H
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S53-6. PubMed ID: 9630327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
    Funada H; Harada M; Yoshida T; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.